Catalent
CTLT
#1601
Rank
C$15.00 B
Marketcap
$82.65
Share price
-0.85%
Change (1 day)
78.51%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Net assets

Net assets on the balance sheet as of September 2024 : C$4.92 Billion

According to Catalent's latest financial reports the company has C$4.92 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Catalent - Net assets on balance sheet (from 2013 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$C$6.10 B-0.69%
2022-06-30$C$6.15 B16.11%
2021-06-30$C$5.29 B10.65%
2020-06-30$C$4.78 B59.42%
2019-06-30$C$3.00 B110.18%
2018-06-30$C$1.42 B52.01%
2017-06-30$C$0.94 B14.29%
2016-06-30$C$0.82 B4.52%
2015-06-30$C$0.78 B-298.44%
2014-06-30$-C$0.4 Billion-8.13%
2013-06-30$-C$0.44 Billion20.87%
2012-06-30$-C$0.36 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$1.40 B-71.57%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.23 Billion-104.63%๐Ÿ‡บ๐Ÿ‡ธ USA
C$5.80 B 17.76%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
C$99.94 M-97.97%๐Ÿ‡บ๐Ÿ‡ธ USA